For medtechs, 2022 will be remembered as one of the most challenging years the industry has seen in decades. The COVID-19 pandemic continued to impact operations for much of the year – especially in China – and disrupted supply chains. In addition, soaring inflation and rising interest rates combined to test the industry’s resilience and drag a big shadow over the global economic outlook.
That was how the ostomy and wound care products company Coloplast Ltd. described the events of 2021-2022. But these...